验证数据展示
经过测试的应用
Positive WB detected in | mouse heart tissue |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
KD/KO | See 2 publications below |
WB | See 2 publications below |
产品信息
19242-1-AP targets SEMA3C in WB, ELISA applications and shows reactivity with human, mouse samples.
经测试应用 | WB, ELISA Application Description |
文献引用应用 | WB |
经测试反应性 | human, mouse |
文献引用反应性 | human |
免疫原 | SEMA3C fusion protein Ag5480 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
别名 | Sema E, SEMA3C, SEMAE, Semaphorin 3C, Semaphorin E, SemE |
计算分子量 | 85 kDa |
观测分子量 | 70 kDa |
GenBank蛋白编号 | BC030690 |
基因名称 | SEMA3C |
Gene ID (NCBI) | 10512 |
RRID | AB_10858635 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q99985 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
SEMA3C (Semaphorin 3C) is associated with tumor progression and poor prognosis across multiple tumor types, including pancreatic, gastric, prostate, and breast cancer, as well as glioma. It is worth noting that full-length SEMA3C has also been reported as a tumor suppressor factor by suppressing tumor lymphangiogenesis and metastasis (PMID: 31649890).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for SEMA3C antibody 19242-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Front Oncol SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis.
| ||
Front Oncol SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.
|